Cymabay Therapeutics (CBAY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CBAY | TEVA | RDY | BBIO | BHC |
| Company | Cymabay Therapeutics | Teva Pharmaceutical Industries ADR | Dr. Reddy's Laboratories Ltd ADR | Bridgebio Pharma Inc | Bausch Health Companies Inc |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NYSE | NASDAQ | NYSE |
| Open | 32.49 | 17.05 | 14.05 | 23.04 | 8.16 |
| High | 32.50 | 17.17 | 14.25 | 23.63 | 8.22 |
| Low | 32.48 | 16.90 | 13.93 | 22.82 | 8.14 |
| Last | 32.48 | 17.05 | 13.99 | 23.40 | 8.15 |
| Change | +0.01 | +0.02 | -0.31 | +0.36 | -0.04 |
| % Change | +0.03% | +0.12% | -2.17% | +1.56% | -0.49% |
| Volume | 8,356,200 | 3,238,641 | 527,269 | 894,266 | 210,139 |
| 20-Day Average Volume | 3,390,805 | 7,462,589 | 789,706 | 1,724,632 | 1,940,397 |
| Previous Close | 32.47 | 17.03 | 14.30 | 23.04 | 8.19 |
| Industry | Medical - Generic Drugs | Medical - Generic Drugs | Medical - Generic Drugs | Medical - Generic Drugs | Medical - Generic Drugs |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 32.35 | 17.58 | 14.74 | 24.48 | 8.81 |
| 20-Day Raw Stochastic | 94.12% | 28.32% | 5.40% | 29.91% | 10.72% |
| 20-Day Relative Strength | 78.00% | 44.43% | 34.15% | 44.31% | 46.95% |
| Weighted Alpha | +247.60 | +60.80 | -2.95 | -26.10 | +8.56 |
| Today's Opinion | 100% Buy | Hold | 56% Sell | 100% Sell | 48% Buy |
| Previous Opinion | 100% Buy | 24% Buy | 56% Sell | 100% Sell | 48% Buy |
| Last Month's Opinion | 100% Buy | 88% Buy | 24% Buy | 100% Sell | 40% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.03% since 03/14/24 | +1.76% since 11/14/24 | -1.51% since 11/14/24 | -2.65% since 11/14/24 | -6.56% since 11/14/24 |
| Low | 32.44 on 03/15/24 | 16.15 on 11/18/24 | 13.93 on 11/21/24 | 21.72 on 11/19/24 | 8.14 on 11/21/24 |
| High | 32.50 on 03/21/24 | 17.17 on 11/21/24 | 14.40 on 11/20/24 | 24.30 on 11/15/24 | 8.73 on 11/15/24 |
| 1-Month | |||||
| %Chg | +0.90% since 02/21/24 | -6.24% since 10/21/24 | -10.94% since 10/21/24 | -6.72% since 10/21/24 | +0.18% since 10/21/24 |
| Low | 32.15 on 02/22/24 | 16.15 on 11/18/24 | 13.93 on 11/21/24 | 21.72 on 11/19/24 | 7.99 on 10/25/24 |
| High | 32.50 on 03/21/24 | 19.31 on 11/06/24 | 15.94 on 10/22/24 | 27.57 on 11/11/24 | 9.85 on 11/04/24 |
| 3-Month | |||||
| %Chg | +46.17% since 12/21/23 | -5.98% since 08/21/24 | -16.73% since 08/21/24 | -8.18% since 08/21/24 | +40.39% since 08/21/24 |
| Low | 22.11 on 01/26/24 | 16.15 on 11/18/24 | 13.93 on 11/21/24 | 21.72 on 11/19/24 | 5.72 on 08/22/24 |
| High | 32.50 on 03/21/24 | 19.31 on 11/06/24 | 16.77 on 08/28/24 | 32.06 on 09/05/24 | 9.85 on 11/04/24 |
| 6-Month | |||||
| %Chg | +122.47% since 09/21/23 | +2.74% since 05/21/24 | +1.75% since 05/21/24 | -19.84% since 05/21/24 | +24.96% since 05/21/24 |
| Low | 12.32 on 10/13/23 | 15.62 on 07/01/24 | 13.61 on 05/31/24 | 21.62 on 06/24/24 | 3.96 on 07/24/24 |
| High | 32.50 on 03/21/24 | 19.31 on 11/06/24 | 16.89 on 08/09/24 | 32.06 on 09/05/24 | 9.85 on 11/04/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 3,726,235 | 19,293,442 | 11,936,224 | 4,354,330 | 3,012,307 |
| Shares Outstanding, K | 114,724 | 1,132,909 | 834,701 | 188,990 | 367,803 |
| Annual Sales | 31,070,000 | 15,846,000,000 | 3,350,000,000 | 9,300,000 | 8,757,000,000 |
| Annual Net Income | -105,370,000 | -559,000,000 | 668,000,000 | -643,200,000 | -592,000,000 |
| Last Quarter Sales | 60,000 | 4,332,000,000 | 953,930,000 | 2,730,000 | 2,510,000,000 |
| Last Quarter Net Income | -41,900,000 | -437,000,000 | 149,380,000 | -162,040,000 | -85,000,000 |
| 60-Month Beta | 0.32 | 0.87 | 0.56 | 1.09 | 0.74 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.35 on 02/28/24 | 0.69 on 11/06/24 | 0.04 on 11/05/24 | -0.86 on 11/12/24 | 1.12 on 10/30/24 |
| Latest Earnings Date | 03/21/24 | 11/06/24 | 11/08/24 | 11/14/24 | 10/30/24 |
| Most Recent Dividend | N/A | 0.072 on 11/27/17 | 0.404 on 07/30/24 | N/A | 1.000 on 11/10/10 |
| Next Ex-Dividends Date | N/A | 11/27/17 | 07/30/24 | N/A | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 6.25 | 22.92 | 0.00 | 2.18 |